Infringement of Swiss-Type Second Medical Use Patent Claims in Germany—Recent Developments in Case Law
Following recent regional court decisions on the infringement of second medical use patent claims, the German concept of manifest arrangement—previously believed to provide a safe harbor for generic pharmaceutical companies as long as they skinny-labeled their products—may be subject to a new interpretation. The German decisions are part of a Europe wide series of decisions on the same or similar subject matter and prove to be patent owner friendly.
Infringement of Swiss-Type Second Medical Use Patent Claims in Germany—Recent Developments in Case Law,
12 Wash. J. L. Tech. & Arts
Available at: https://digitalcommons.law.uw.edu/wjlta/vol12/iss3/4
Comparative and Foreign Law Commons, Food and Drug Law Commons, Intellectual Property Law Commons